Type І hyper IgM syndrome with novel mutation from India.

Area of Science:

• Immunology
• Genetics
• Hematology

Background:

• Primary immunodeficiency disorders (PIDs) encompass a heterogeneous group of genetic defects.
• Hyper IgM syndrome (HIGM) is a PID characterized by elevated IgM and deficient other immunoglobulin isotypes.
• Defective CD40 Ligand (CD40L) on T cells impairs T-B lymphocyte interaction and immunoglobulin class switching.

Observation:

• This report details a patient diagnosed with X-linked Hyper IgM syndrome (XHIGM).
• The patient presented with a novel mutation identified in the CD40 Ligand (CD40L) gene.
• The clinical course was complicated by the genetic defect affecting immune cell communication.

Findings:

• A novel mutation in the CD40 Ligand (CD40L) gene was identified as the cause of XHIGM in this patient.
• The mutation resulted in a deficiency of functional CD40L, disrupting T-cell and B-cell interactions.
• The inability to switch antibody production from IgM to other immunoglobulin classes was observed.

Implications:

• This case highlights the importance of genetic diagnosis in primary immunodeficiencies.
• Successful bone marrow transplantation offers a potentially curative treatment for XHIGM.
• Understanding CD40L mutations advances knowledge of immune regulation and therapeutic strategies for PIDs.